Clinical Trials
4 trialsNCT02954874 2026-05-15
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT05601440 2026-05-07
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT03503799 2026-04-13
RESCUE
North Eastern German Society of Gynaecological Oncology
Active not recruiting
NCT07447440 2026-03-11
RESOLBE
Clinica Universidad de Navarra, Universidad de Navarra
Recruiting